Lukasz Laczmanski

Has grant

vice head of the laboratory, diagnostician

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Microbiology Microbiology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Lukasz Laczmanski is the Vice Head of the Laboratory and a diagnostician at the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy in Poland. His research interests encompass gene editing technologies, lipid nanoparticles for therapeutic delivery, and microbiome studies, as evidenced by his recent articles on COL7A1 correction in epidermolysis bullosa and airway bacterial biodiversity in asthmatic children. Additionally, his work includes analyzing cardiometabolic risks and the implications of humoral responses in vaccination.

Recent Grants

Grant: Close

Strengthening CBRNE safety and security – Coordination and Standardization

Open Date: 2020-07-01

Close Date: 2024-03-01

Grant: Close

The role of gut microbiota and permeability in the pathophysiology of schizophrenia - in search of the mechanisms underlying subthreshold inflammatory state and metabolic dysregulation

Open Date: 2019-07-01

Close Date: 2022-07-01

Grant: Close

BINWIT - Scientific Information Base Supporting Innovative Therapies

Open Date: 2018-08-01

Close Date: 2021-07-01

Grant: Close

Wpływ polimorfizmów genu receptora witaminy D (VDR) oraz polimorfizmów genu receptora wapniowego (CASR) na przebieg Choroby Alzheimera.

Open Date: 2011-12-07

Close Date: 2014-12-06

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Damian Skrypnik

Poznan University of Medical Sciences

POLAND

Lukasz Laczmanski

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Porous Silicon Nanoneedles Efficiently Deliver Adenine Base Editor to Correct a Recurrent Pathogenic COL7A1 Variant in Recessive Dystrophic Epidermolysis Bullosa

<i>HvGSK1.1</i> Controls Salt Tolerance and Yield through the Brassinosteroid Signaling Pathway in Barley

Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro

Characteristics of Environmental <i>Klebsiella pneumoniae</i> and <i>Klebsiella oxytoca</i> Bacteriophages and Their Therapeutic Applications

NGS Sequencing Reveals New UCP1 Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population—A Preliminary Study

Assessment of Cardiometabolic Risk Reveals Elevated C-Reactive Protein Levels in Patients with Deficit Schizophrenia after Adjustment for Lifestyle Characteristics

How Humoral Response and Side Effects Depend on the Type of Vaccine and Past SARS-CoV-2 Infection

Homeostasis of the Intestinal Mucosa in Healthy Horses-Correlation between the Fecal Microbiome, Secretory Immunoglobulin A and Fecal Egg Count.

Machine-learning-based analysis identifies miRNA expression profile for diagnosis and prediction of colorectal cancer: a preliminary study

Airway Bacterial Biodiversity in Exhaled Breath Condensates of Asthmatic Children—Does It Differ from the Healthy Ones?

Co-toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis

Collaborators (22)

Damian Skrypnik

Pawel Karpinski

Ciro Chiappini

Mateusz Chmielarz

Pawel Bogdanski

Agnieszka Piwowar

Anna Nadolska-Orczyk

Anna Chelmonska-Soyta

Beata Jankowska-Polanska

Patryk Piotrowski

Maciej Karczewski

Andrzej Gorski

Waclaw Orczyk

Ernest Tyburski

Emanuel Rognoni

Marta Dmochowska-Boguta

Joanna Jackow

Malgorzata Lobocka

Anna Andrzejczak

Bogumiła Szponar

Marzanna Łusiak-Szelachowska

Malgorzata Zalewska

Make your next move.